NCT04194645View on ClinicalTrials.gov

A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink.

PHASE1CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

March 25, 2021

Study Completion Date

March 25, 2021

Conditions
Healthy
Interventions
DRUG

BI 474121 tablet

BI 474121 tablet

DRUG

Placebo tablet

Placebo tablet

DRUG

BI 474121 oral solution

BI 474121 oral solution

DRUG

Placebo solution

Placebo solution

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04194645 - A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 474121, and Whether it Makes a Difference if BI 474121 is Taken as a Tablet or a Drink. | Biotech Hunter | Biotech Hunter